http://www.thiomatrix.com/img/flash%20files/flaintro.png
 

 

 


OR  AND 

 

 

 

in vitro / ex vivo STUDIES

 

SOLUBILITY ENHANCEMENT STUDIES

 

ThioMatrix has great experience in formulation of poorly soluble APIs. In order to overcome solubility problems, ThioMatrix has developed a rational screening platform aimed at finding cost-effective and quick solutions to support such studies. After a solubility screening and cristallinity assessment the identified poor solubility of APIs can bee enhanced by:

  • solidlid-state modifications such as salt formation, particle size reduction or solid-state stabilization of the amorphous state

  • addition of co-solvents

  • development of lipid based systems such as microemulsions

  • formation of complexes such as with cyclodextrins

  • addition of additives such as surfactants or polymer

  • Sufficient solubility is a prerequisite for essential in vitro analyses such as permeation studies and subsequently the development of highly efficient drug delivery systems.


Sufficient solubility is a prerequisite for essential in vitro analyses such as permeation studies and subsequently the development of highly efficient drug delivery systems.

 

 

 

Research Center Innsbruck:
Trientlgasse 65
6020 Innsbruck, Austria
Tel.: +43 512 890046-0
Fax.: +43 512 890046-15
e-mail: info@thiomatrix.com
Business Center St. Veit:
Unterer Platz 22
9300 St. Veit a.d. Glan, Austria
Tel: +43 650 7536270
Fax: +43 650 75362702
e-mail: info@thiomatrix.com

 

(c) All rights reserved | Site Map | Disclaimer | Imprint | Contact |